Lenz HJ - Search Results

1

Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.

Winder T, Zhang W, Yang D, Ning Y, Bohanes P, Gerger A, Wilson PM, Pohl A, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ. Winder T, et al. Among authors: lenz hj. Clin Cancer Res. 2010 Nov 15;16(22):5591-602. doi: 10.1158/1078-0432.CCR-10-2092. Epub 2010 Oct 8. Clin Cancer Res. 2010. PMID: 20935157 Free PMC article.

2

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma.

Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Oncol Rep. 2002 Mar-Apr;9(2):235-8. Oncol Rep. 2002. PMID: 11836586

3

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Int J Colorectal Dis. 2002 Jan;17(1):46-9. doi: 10.1007/s003840100358. Int J Colorectal Dis. 2002. PMID: 12018454

4

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936. J Natl Cancer Inst. 2002. PMID: 12072547

5

Molecular predictors of treatment and outcome in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Curr Gastroenterol Rep. 2003 Oct;5(5):399-405. doi: 10.1007/s11894-003-0053-3. Curr Gastroenterol Rep. 2003. PMID: 12959721 Review.

6

Pharmacogenetic aspects in treatment of colorectal cancer--an update.

Stoehlmacher J, Goekkurt E, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Pharmacogenomics. 2003 Nov;4(6):767-77. doi: 10.1517/phgs.4.6.767.22825. Pharmacogenomics. 2003. PMID: 14596640 Review.

7

Integration of novel agents in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. doi: 10.1007/s00280-004-0884-0. Cancer Chemother Pharmacol. 2004. PMID: 15309512 Review.

8

Tailored chemotherapy for colorectal cancer: a new approach to therapy.

Iqbal S, Stoehlmacher J, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer Invest. 2004;22(5):762-73. doi: 10.1081/cnv-200032774. Cancer Invest. 2004. PMID: 15581057 Review.

9

Angiogenesis inhibitors in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Semin Oncol. 2004 Dec;31(6 Suppl 17):10-6. doi: 10.1053/j.seminoncol.2004.11.029. Semin Oncol. 2004. PMID: 15696025 Review.

10

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: lenz hj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters